SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: (Original Filing)

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:11:38+00:00 August 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: PART II — RULES 12b-25(b) AND (c) ½

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:12:24+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: (Original Filing)

[PART II -- RULES 12b-25(b) AND (c) [ X ] (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed]

By | 2016-02-05T03:33:47+00:00 August 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: PART II — RULES 12b-25(b) AND (c) [

[PART II -- RULES 12b-25(b) AND (c) [ X ] (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed]

By | 2016-02-05T03:34:36+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY N/A Former name if applicable: 9595 Wilshire Blvd., Suite 900 Beverly Hills, California 90212 City, state and zip code PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; x (b) The subject annual report, semi-annual report, transition]

By | 2016-03-01T05:23:31+00:00 May 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: SKYSTAR BIO-PHARMACEUTICAL COMPANY N/A Former name if applicable:

[SKYSTAR BIO-PHARMACEUTICAL COMPANY N/A Former name if applicable: 9595 Wilshire Blvd., Suite 900 Beverly Hills, California 90212 City, state and zip code PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; x (b) The subject annual report, semi-annual report, transition]

By | 2016-03-01T05:24:02+00:00 May 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY N/A Former name if applicable: 9595 Wilshire Blvd., Suite 900 Beverly Hills,lifornia 90212 City, state and zipde PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense;]

By | 2016-02-05T03:41:14+00:00 May 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY N/A Former name if applicable: 9595

[SKYSTAR BIO-PHARMACEUTICALMPANY N/A Former name if applicable: 9595 Wilshire Blvd., Suite 900 Beverly Hills,lifornia 90212 City, state and zipde PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense;]

By | 2016-02-05T03:42:01+00:00 May 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar